224
Participants
Start Date
August 2, 2022
Primary Completion Date
May 10, 2023
Study Completion Date
May 13, 2023
Flumazenil
During the procedure, continuous infusion of remimazolam dose of 2mg/kg/hr. when procedure ends, infusion remimazolam stops and 0.9% normal saline or 0.2mg of flumazenil according to allocated groups.
Konkuk University Medical Center, Seoul
Konkuk University Medical Center
OTHER